Tianxu Hao, Zhenchun Song, Jiechun Li, Rui Suo, Yan Li, Yibei Lu, Ximing Li, Dongxia Jin
{"title":"“RotaTripsy” as State-of-the-Art Strategy for Coronary Artery Calcification: A Scoping Review","authors":"Tianxu Hao, Zhenchun Song, Jiechun Li, Rui Suo, Yan Li, Yibei Lu, Ximing Li, Dongxia Jin","doi":"10.1155/cdr/3713315","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> Recently, the combination of rotational atherectomy (RA) with intravascular lithotripsy (IVL), known as “RotaTripsy,” has been employed in the treatment of coronary lesions with severe calcification. In this article, we provide an overview of the current evidence regarding this technique, emphasizing the importance of appropriate patient and lesion selection to achieve optimal clinical outcomes, including the primary goal of improvement of stenting and enhancement of short and long-term prognosis.</p><p><b>Methods:</b> We performed a systematic literature search using PubMed, Embase, Web of Science, and Cochrane library up to July 2024 for studies that combined RA and IVL for coronary artery calcification lesions that were included. The retrieved articles and references of the primary articles were used to collect the basic information. SPSS 20.0 and Excel statistic software were used to conduct this scoping review.</p><p><b>Results:</b> A total of 25 studies consisting of 259 patients were identified. Of all the patients, 208 (80.3%) were male. Patients had an average age of 68.31 years, and 119 (45.95) patients had acute coronary syndrome. In addition, 218 (84.17%) had hypertension, 128 (49.42%) had diabetes mellitus, and 48 (18.53%) had chronic kidney disease. In the ultimate analysis, 252 patients (97.3%) successfully underwent the “RotaTripsy” procedure, with a minimal mortality rate of only 7 individuals (2.7%) during the follow-up period.</p><p><b>Conclusions:</b> “RotaTripsy,” as an efficacious therapeutic modality, shows its unique potential for severe calcified coronary artery lesions resistant to dilation. Our research findings substantiate its feasibility, safety, and effectiveness in clinic.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2025 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/3713315","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/3713315","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Recently, the combination of rotational atherectomy (RA) with intravascular lithotripsy (IVL), known as “RotaTripsy,” has been employed in the treatment of coronary lesions with severe calcification. In this article, we provide an overview of the current evidence regarding this technique, emphasizing the importance of appropriate patient and lesion selection to achieve optimal clinical outcomes, including the primary goal of improvement of stenting and enhancement of short and long-term prognosis.
Methods: We performed a systematic literature search using PubMed, Embase, Web of Science, and Cochrane library up to July 2024 for studies that combined RA and IVL for coronary artery calcification lesions that were included. The retrieved articles and references of the primary articles were used to collect the basic information. SPSS 20.0 and Excel statistic software were used to conduct this scoping review.
Results: A total of 25 studies consisting of 259 patients were identified. Of all the patients, 208 (80.3%) were male. Patients had an average age of 68.31 years, and 119 (45.95) patients had acute coronary syndrome. In addition, 218 (84.17%) had hypertension, 128 (49.42%) had diabetes mellitus, and 48 (18.53%) had chronic kidney disease. In the ultimate analysis, 252 patients (97.3%) successfully underwent the “RotaTripsy” procedure, with a minimal mortality rate of only 7 individuals (2.7%) during the follow-up period.
Conclusions: “RotaTripsy,” as an efficacious therapeutic modality, shows its unique potential for severe calcified coronary artery lesions resistant to dilation. Our research findings substantiate its feasibility, safety, and effectiveness in clinic.
背景:最近,旋转动脉粥样硬化切除术(RA)联合血管内碎石术(IVL),被称为“旋转碎石术”,已被用于治疗严重钙化的冠状动脉病变。在本文中,我们概述了目前关于该技术的证据,强调了适当的患者和病变选择对于获得最佳临床结果的重要性,包括改善支架置入和增强短期和长期预后的主要目标。方法:我们使用PubMed、Embase、Web of Science和Cochrane图书馆进行了系统的文献检索,检索截止到2024年7月,包括RA和IVL联合治疗冠状动脉钙化病变的研究。利用检索到的文献和主要文献的参考文献收集基本信息。采用SPSS 20.0和Excel统计软件进行范围审查。结果:共纳入25项研究,共纳入259例患者。其中男性208例(80.3%)。患者平均年龄68.31岁,急性冠脉综合征119例(45.95例)。此外,高血压218例(84.17%),糖尿病128例(49.42%),慢性肾病48例(18.53%)。在最终分析中,252例患者(97.3%)成功地接受了“RotaTripsy”手术,随访期间死亡率最低的只有7例(2.7%)。结论:“旋切术”作为一种有效的治疗方式,显示出其对难以扩张的严重钙化冠状动脉病变的独特潜力。我们的研究结果证实了该方法的可行性、安全性和临床有效性。
期刊介绍:
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.